# ROBO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/robo

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.docrobo.com/
- Latest round: Series B (May 25, 2026)
- Investors on record: 3

## About

Based in Shenzhen, China and established in 2015, Shenzhen Robo Medical Technology Co.,Ltd, trading as ROBO, operates as a flexible gastrointestinal endoscopic surgery robot developer that provides gastrointestinal endoscopic surgery robots and sterilization robots. The company cooperates with Qilu Hospital of Shandong University and Shanghai Changhai Hospital. The core research team comes from EPFL and HIT, and more than 70% have master's degree. In December 2020, the company launched research project on intelligent upper limb prosthesis with bidirectional neural pathways. In May 2026, ROBO raised a series B+ funding led by Tsinghua Innovation Ventures, with participation from Boyue Tiancheng.

The company's products include gastrointestinal endoscopic surgery robots and sterilization robots. Product can apply in clinical areas such as transnatural cavity surgery and ultrasound diagnosis. 

The company generates revenue by providing gastrointestinal endoscopic surgery robots and sterilization robots. 

The company will use the latest funding for the nationwide clinical rollout of the core product, the EndoFaster® digestive endoscopic surgical robot; the research and development of the next-generation product, EndoDreams; the construction of an intelligent production base and supply chain optimization; and international market certification and hospital promotion.

## Funding rounds

- Series B, May 25, 2026 — Tsinghua Innovation Ventures
- Series A, Nov 6, 2024 — Guoshun Investment
- Series A, Jun 5, 2023 — Tailong VC

## Investors

- Tailong VC (https://capitalatlas.ai/funds/tailong-vc) — Series A
- Guoshun Investment (https://capitalatlas.ai/funds/guoshun-investment) — Series A
- Tsinghua Innovation Ventures (https://capitalatlas.ai/funds/tsinghua-innovation-ventures) — Series B